Concepedia

Author

Daniel Grima

Cornerstone Research Group (United States)ORCID

Also Known As

D Grima, D T Grima, D. Grima, D. T. Grima, D.T Grima, D.T. Grima, DANIEL T. GRIMA, Daniel Grima, Daniel T Grima, Daniel T. Grima

96

Publications

2.1K

Citations

20

H-Index

58

Concepts

All Affiliations

Cornerstone Research Group (United States)McMaster UniversityHarvard UniversityProcter & Gamble (United States)Cornerstone University
DG

About

Daniel Grima is an author at Cornerstone Research Group (United States) specializing in medicine, health economics, and outcomes research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

896

2

Public Health

3

3

630

3

Cell Biology

1

1

33

4

Cellular Therapies

1

1

33

5

Diabetes

1

1

49

Daniel Grima

×

33

Publications

2.1K

Citations

20

H-Index

YearCitations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

S. J. Goldie, Michele Kohli, Daniel Grima,

JNCI Journal of the National Cancer Institute

2004

535

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine

Sue J. Goldie, Daniel Grima, Michele Kohli,

International Journal of Cancer

2003

211

A Microsoft-Excel-based tool for running and critically appraising network meta-analyses—an overview and application of NetMetaXL

Stephen Brown, Brian Hutton, Tammy Clifford,

Systematic Reviews

2014

204

Cost and health related quality of life consequences of multiple sclerosis

Daniel Grima, George W. Torrance, G. Francis,

Multiple Sclerosis Journal

2000

149

Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

Deborah A. Marshall, Steven Kleinman, John B. Wong,

Vox Sanguinis

2004

139

Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis

Colin A. Hutchison, Nils Heyne, Parisa Airia,

Nephrology Dialysis Transplantation

2012

124

Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions

Anna N.A. Tosteson, Bengt Jönsson, Daniel Grima,

Osteoporosis International

2001

100

Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada

Daniel Grima, Melissa F Thompson, Luc Sauriol

PharmacoEconomics

2007

49

Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis

Daniel Grima, Lisa Bernard, Elizabeth S. Dunn,

PharmacoEconomics

2012

46

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

Andrew Rosner, Daniel Grima, George W. Torrance,

PharmacoEconomics

1998

39

Page 1